EQUIOXX® (firocoxib) Use in Horses
by Robert N. Oglesby DVM
Introduction
Introduction
»
Studies
»
Compare to Phenylbutazone
»
Safety Studies
»
Precautions
»
Adverse Reactions
»
Costs
»
Dosage
»
How Supplied
»
More Info
EQUIOXX is an oral paste produced by Merial containing firocoxib, a coxib class of non-narcotic, non-steroidal anti-inflammatory drug (NSAID). Coxib class is a term for what has been called cyclooxygenase-inhibiting or COX-2 inhibitors. This class of NSAID's is thought to be safer than earlier NSAID's because of lower risk of GI irritation. EQUIOXX has been approved for use in horses by the FDA and is now sold in the USA. This article discusses the dosage, efficacy, safety, cost, and use of firocoxib and compares it with phenylbutazone use in the horse.
~Word Count: 1616 words (The average magazine page contains about 600 words);
~Last Updated: September 08, 2009;
There are 2 ways to access the complete article:
You have just read the introduction to one of our nearly 800 articles on horse care, diseases, and training. It includes a description of the contents of the unabridged version. As a guest you can access this article two different ways: either purchase the article or become a member and take advantage of all the benefits Horseadvice.com has to offer.
Check out our Membership Drive Discount below but hurry. This is for a limited time!

Your assurance of excellent customer service.

We use 128 bit SSL encryption, so your order is secure.